Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c oxidase subunit 8C, mitochondrial (COX8C), is a nuclear-encoded protein subunit of cytochrome c oxidase (complex IV), the terminal enzyme of the mitochondrial electron transport chain[1][7]. Complex IV catalyzes the reduction of molecular oxygen to water, a critical step in oxidative phosphorylation that enables ATP production. COX8C is one of several nuclear-encoded, stoichiometric, non-catalytic subunits that participate in the assembly, stability, and possible regulation of cytochrome c oxidase, though it does not contribute directly to the active (catalytic) sites[1][4][7]. Mutations or deficiencies in complex IV subunits, including COX8C, can disrupt electron transfer, abolish oxidative phosphorylation, and cause severe mitochondrial diseases involving energy-deficient tissues such as brain, heart, and skeletal muscle[1][3][6][7]. There is currently no evidence for direct targeting of COX8C by drugs or use as a selective clinical biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c oxidase subunit 8C, mitochondrial (COX8C).